학술논문
Two-year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 months
Document Type
Article
Author
Source
In: Allergy: European Journal of Allergy and Clinical Immunology . (Allergy: European Journal of Allergy and Clinical Immunology, October 2023, 78(10):2684-2697)
Subject
Language
English
ISSN
13989995
01054538
01054538